Objective: After menopause, women are at an increased risk of cardiovascular disease. The present study assessed cardiovascular hemodynamics in premenopausal versus postmenopausal women, with a focus on systemic vascular resistance (SVR) at rest and during stress. Sympathetic nervous system activity and cardiovascular adrenergic receptor (AR) function were also examined.
C oronary heart disease risk in women increases dramatically after menopause, 1<4 ultimately accounting for about one third of all deaths in women. 5 Epidemiological evidence suggests that changes in female reproductive hormones, particularly the decline in estrogen, are primary factors contributing to this increased risk of coronary heart disease among postmenopausal women. 2, 3, 6, 7 In addition to beneficial effects on the lipid profile, estrogen causes vasodilation through both direct and indirect effects on the vasculature. 8<13 Therefore, when plasma estrogen levels fall dramatically after menopause, similar levels of blood pressure (BP) may be maintained with a lower cardiac output (CO) and higher systemic vascular resistance (SVR). The purpose of this study was to examine cardiovascular hemodynamics at rest and during stress in premenopausal and postmenopausal women. We hypothesized that postmenopausal women would show increased SVR at rest and during stress as well as larger SVR responses during stress compared with premenopausal women. Plasma catecholamines and adrenergic receptor (AR) responsiveness were examined as potential contributors to the hemodynamic effects of menopause.
METHODS

Participants
Women were recruited through advertisements in local newspapers. Recruitment was designed to obtain samples of premenopausal and postmenopausal women who were matched by age, weight, ethnicity, and BP. Telephone screening was used to establish whether potential participants met the study's inclusion/exclusion criteria. More than 90% of both premenopausal and postmenopausal women presenting for screening physical examination were eligible to participate in the study, provided consent, and enrolled.
A total of 90 women (45 premenopausal and 45 postmenopausal women) aged 47 to 56 years comprised the study sample. The study protocol was reviewed and approved by Duke University Medical Center's institutional review board, and all participants provided verbal and written consent before participation. Exclusion criteria included use of exogenous reproductive hormones (eg, hormone therapy and oral contraceptives); having undergone hysterectomy; having a history of cardiovascular disease or systemic disease affecting the cardiovascular system; having hypertension, defined as BP higher than 160/100 mm Hg on BP screening examination; chronic use of drugs that alter systemic hemodynamics (including antihypertensives, antidepressants, and sympathomimetic agents); and current tobacco or illegal drug use. Women who reported regular menstruation were considered premenopausal, and women who had not menstruated in at least 9 months were considered postmenopausal. Reproductive hormone assays were used to further document menopause status. Sample characteristics are reported in Table 1 .
Hormone assessment
Blood (2 mL) was drawn from an antecubital vein, collected into a serum-separator tube, and refrigerated. The sample was analyzed within 12 hours of collection using an immunochemiluminometric assay (Labcorp Inc, Burlington, NC) to determine concentrations of estrogen, progesterone, folliclestimulating hormone (FSH), and luteinizing hormone (LH). Performance characteristics for these assays were as follows: estrogen range, 10 to 1,000 pg/mL; progesterone range, 0.1 to 40 ng/mL; FSH range, 0.3 to 200 mIU/mL; and LH range, 0.07 to 200 mIU/mL.
Catecholamine measurement
To obtain resting plasma epinephrine and norepinephrine (NE) values, blood was sampled from a cannula inserted into a forearm vein and connected by heparin-treated polyethylene tubing to a blood withdrawal pump (Cormed ML6 continuous blood withdrawal system; Dakmed, Inc, Buffalo, NY). Blood was drawn at a rate of 3 mL/minute into chilled ethylenediaminetetraacetic acidYtreated tubes. Samples were placed on ice and were cold centrifuged, and plasma was pipetted and frozen at j80-C until assay. Assays were performed using high-performance liquid chromatography procedures. The lower limit of quantification using the highperformance liquid chromatography method is 25 pg/mL, and the intraday and interday coefficients of variation are less than 10%.
Cardiovascular measures
Blood pressure was measured using a SunTech 4240 automatic auscultatory BP monitor. A minimum of three stethoscopic auscultatory readings were made concurrently with the automatic ausculatory readings by a trained staff member to ensure optimal placement of the electrocardiogram (ECG) electrodes and the Korotkoff sound microphone.
Impedance cardiography signals were recorded via a Minnesota Impedance Cardiograph (model HIC-1; Bio-Impedance Technology, Chapel Hill, NC) using a tetrapolar band-electrode configuration. The recording electrode bands were positioned around the base of the neck and around the thorax, over the xiphisternal junction. The current electrode bands were positioned to encompass the neck and thorax, at least 3 cm away from each of the recording electrodes. The ECG was recorded from the Minnesota Impedance Cardiograph using disposable ECG electrodes. The basal thoracic impedance (Zo), the first derivative of the pulsatile impedance (dZ/dt), and the ECG waveforms were processed using a specialized ensemble-averaging software (COP; BIT Inc, Chapel Hill, NC), which was used to derive stroke volume using the Kubicek equation. 14 
Cardiac output
After instrumentation, CO obtained from the impedance cardiography system was calibrated against a pulsed-Doppler system. The Doppler system was used to measure ascending aortic blood flow velocity during cardiac cycles occurring during the first 30 seconds of five consecutive minutes. Impedance cardiographic signals were recorded during the exact same five 30-second periods. The CO values derived from the Doppler flow measures were used to scale all impedance volumeYbased measures, CO, stroke volume, and SVR, to absolute values. For example, if resting calibration Doppler stroke volume was 10% lower than for impedance, a scale factor of 0.9 was applied to impedance stroke volume measures. This strategy provided a means of estimating absolute CO and extends the widely accepted validity of impedance cardiography as a reliable method for measuring changes in CO over time. 15 Finally, all CO measurements were divided by body surface area, to provide an index of CO adjusted for body size (LImin j1 Im j2 ).
Systemic vascular resistance
The following equation was used to derive SVR:
where MAP is mean arterial pressure (mm Hg) and CO is cardiac output (L/min), with MAP = diastolic BP [DBP] + (systolic BP [SBP] j DBP)/3. SVR was adjusted for body size by multiplying by body surface area.
Laboratory stress testing protocol
Participants completed the laboratory protocol at least 6 hours after the most recent consumption of caffeine. All test procedures were conducted while participants were seated in an electrically shielded, sound-attenuated, temperature-controlled (24-C) room. After instrumentation with the BP monitor and the impedance cardiograph, participants were seated in a comfortable chair and asked to relax as much as possible for 20 minutes. Resting baseline cardiovascular measures were obtained once each minute during the last 3 minutes of this relaxation period. Blood drawn over this same 3-minute period was used to determine resting baseline plasma catecholamines. Participants then completed four laboratory stress tasks, separated by 3-minute rest periods; balance for order of task presentation was achieved using a Williams' square design. Cardiovascular measures were recorded each minute during these tasks.
Anger interview
The anger interview (AI) required participants to recall an incident from their lives that made them feel angry and that also involved active interpersonal interaction. Participants were given 3 minutes to prepare and 3 minutes to describe the incident to the interviewer. Participants described the scenario first, then their emotions and interpersonal interactions, followed by a summary of the outcome and their level of satisfaction with their behavior in the situation. The AI is considered ecologically valid and has been found to produce large increases in BP, similar to public-speaking tasks, but with a greater hemodynamic contribution from increased vascular resistance. 16 
Reaction-time shock avoidance
The reaction-time shock avoidance (RT) consisted of a 3-minute task during which a loud audible tone was presented at varying, unpredictable intervals (average, 23 s). Participants were told to press a key as fast as possible upon hearing each tone. They were further instructed that a Bpainful but harmless[ electric shock would be immediately delivered by electrodes previously applied to the leg if, on any given trial, a reaction time was considered too slow. In fact, no shocks were delivered. The RT is considered a potent means of eliciting BP increases mediated predominantly by A-adrenergic mechanisms. 17 
Mirror trace
In this 3-minute task, the participants were required to trace the shape of a star using a metal stylus guided only by its reflection in a mirror. Participants were told to trace the shape as many times as possible without making any errors associated with deviating beyond the narrow boundaries of the star shape. Errors caused an aversive buzzing sound and were recorded with a digital counter. The mirror trace (MT) is considered an >-adrenergic stimulus and has been associated with perceived frustration and increased SVR. 18 
Foot cold pressor
The cold pressor (CP) required the participants to immerse their foot, up to the ankle, in a mixture of ice and water (0-C-4-C) for 100 seconds. The CP results primarily in an increase in SVR due to >-adrenergic stimulation. 19 
Cardiovascular measurements during receptor responsiveness testing
All receptor responsiveness testing was conducted on a separate day from the laboratory stress testing protocol. Participants were completely reclined and had not consumed caffeine for at least 6 hours. Blood pressure was measured continuously using the Finapres (Ohmeda, Madison, WI) noninvasive BP monitor, which uses the vascular unloading technique to measure SBP, DBP, and mean BP on a beat-bybeat basis. This instrument has been validated against intraarterial measures under various conditions, including pressor responses to phenylephrine. 20 Heart rate (HR) was derived from an ECG as the interval between successive R waves.
A-AR responsiveness
A-AR responsiveness was assessed using an isoproterenol sensitivity test. Cardiac A-AR responsiveness was indexed as the chronotropic dose of isoproterenol required to increase HR by 25 beats/minute (CD 25 ). 21 Progressively increasing bolus doses of isoproterenol (0.125, 0.25, 0.5, 1.0, 2.0, and 4.0 Kg) were injected into an antecubital vein until an increase in HR of at least 25 beats/minute was observed. HR responses after each dose were computed as the shortest three successive ECG R-R intervals after drug injection, compared with the shortest three R-R intervals at rest (preinjection). After each dose, the next higher dose was not injected for at least 5 minutes, or until cardiovascular activity had returned to resting levels, usually within 5 to l0 minutes. The linear regression model of log-dose/HR response for each participant was used to determine CD 25 exactly by interpolation. The CD 25 measure provides an index of cardiovascular A 1 -and A 2receptor responsiveness and is inversely related to receptor responsiveness.
> 1 -AR responsiveness
A procedure analogous to the A-AR responsiveness test described above was used for assessing > 1 -AR responsiveness, using the > 1 agonist phenylephrine to stimulate vascular > 1 receptors. 22 In this test, the criterion response is defined as the dose required to increase MAP by 25 mm Hg (PD 25 ). An initial dose of 25 Kg phenylephrine was used, with successive doses doubled until the 25 mm Hg response was exceeded, or until a maximal dose of 800 Kg. Again, at least 5 minutes, or longer if required for recovery of cardiovascular activity to resting levels, preceded administration of successive doses. The linear log-dose/MAP response curve was used to determine the exact PD 25 dose. The PD 25 index is inversely related to vascular > 1 -AR responsiveness.
Data analytic strategy
Two-factor (menopause Â ethnicity) analyses of variance were used to evaluate the effects of menopause, ethnicity, and menopause-by-ethnicity interactions on clinical characteristics (Table 1) . Similar models were used to evaluate premenopausal versus postmenopausal differences in the hemodynamic and sympathetic nervous system (SNS) characteristics ( Table 2 ). Analyses involving the CD 25 index of cardiac A-AR responsiveness included baseline HR as a covariate, and analyses involving the PD 25 index of vascular >-AR responsiveness included baseline SBP as a covariate. To assess whether observed effects were independent of age, body mass index (BMI), and cholesterol levels, additional analyses of covariance (ANCOVAs) were performed that included these characteristics as covariables.
Baseline hemodynamic measurements (SBP, DBP, HR, stroke volume, CO, and SVR) were computed as the mean of the three measurements taken during the last 3 minutes of the 20-minute initial relaxation period. Cardiovascular measurements were taken every minute during each of the stress tasks, and response to the stressor was defined as the mean of the minute-by-minute readings taken during the task. Hemodynamic responses to the stress tasks were examined using three-factor (menopause Â ethnicity Â task) repeated-measures ANCOVAs, in which all two-way interactions and the threeway interaction 5 were evaluated. Primary analyses included baseline as a repeated-measures condition, to evaluate the persistence of any menopausal effects across resting and stress conditions; confirmatory analyses examined the moderating effects of menopause status on stress responses, with corresponding baseline measurement included as a covariate. These analyses were also repeated, controlling for age, BMI, and cholesterol levels. P G 0.05 was considered significant.
RESULTS
Demographic and clinical characteristics
Demographic and clinical characteristics are presented in Table 1 . Postmenopausal women were older by an average of 2 years than premenopausal women (P G 0.01), and total cholesterol level was higher in postmenopausal than premenopausal women (P G 0.01). Sample characteristics of reproductive hormone assays are also reported in Table 1 , with expected premenopausal versus postmenopausal differences in estrogen, progesterone, FSH, and LH levels (Ps G 0.001). There were no ethnic differences, nor ethnicity-by-menopause interactions, for the characteristics shown in Table 1 .
Baseline cardiovascular measures
Baseline values of cardiovascular measures are presented in Table 2 . Analyses of variance comparing menopause and ethnic groups with respect to baseline hemodynamic measures revealed that premenopausal women exhibited higher baseline CO than did postmenopausal women (P G 0.001), as well as lower baseline SVR (P G 0.001). No other main effects or interactions involving ethnic and menopause status were observed for HR, BP, CO, and SVR. Because of problems establishing a venous line and sample contamination, plasma NE assays were available only for a subset of 73 participants and epinephrine assays were available only for a subset of 64 participants. Postmenopausal women had higher resting plasma NE levels than did premenopausal women (P = 0.007) but did not differ in resting epinephrine level. Differences in baseline CO, SVR, and NE level between premenopausal and postmenopausal women remained significant after controlling for age and BMI.
AR responsiveness
Complete >-and A-AR responsiveness testing data were available for 74 women because of difficulties establishing a venous infusion line in the remaining study participants. Analyses of variance comparing menopause and ethnic groups with respect to baseline catecholamine values revealed that no menopausal differences were observed for the PD 25 index of >-AR responsiveness. However, in postmenopausal women, significantly higher values for the CD 25 index of A-AR responsiveness were found than in premenopausal women (P = 0.02). However, this menopausal difference in CD 25 was no longer evident after controlling for age and BMI. There were no ethnic differences or interactions between menopause status and ethnicity involving these measures.
Hemodynamic responses to stressors
Results of ANCOVAs comparing menopause and ethnic groups with respect to cardiovascular measures at rest and during each of the laboratory stress tasks revealed that the tasks altered cardiovascular activity for all response measures (Ps G 0.001). Planned contrasts revealed that HR, SBP, and DBP were higher during each task than during baseline (Ps G 0.0001). CO increased during AI, RT, and CP (Ps G 0.05) but was not significantly different from baseline during MT (P = 0.08). Relative to baseline, SVR values decreased during AI and RT (Ps G 0.05) and increased during MT (P = 0.056) and CP (P G 0.001).
A significant main effect of menopause status revealed that postmenopausal women had lower CO values throughout the laboratory protocol (P = 0.004). Postmenopausal women also exhibited higher SVR values throughout the protocol (P = 0.002). These menopausal effects for CO and SVR remained unaltered after age and BMI were included as covariates. No main effects were observed for ethnicity, and no interactions involving menopause status, ethnicity, or the repeated-measures factor (task) were observed. Repeatedmeasures ANCOVAs focusing on task responses, incorporating corresponding baseline values as covariates, confirmed that menopause status did not moderate task responses (menopause effects and menopause-by-task interactions all nonsignificant), supporting the interpretation that menopausal differences in CO and SVR at resting baseline simply persisted, rather than be enhanced or attenuated, during exposure to the stress tests. Values of SBP, DBP, CO, and SVR for premenopausal and postmenopausal women at each phase of the laboratory protocol are presented in Fig. 1 .
DISCUSSION
Our observations that postmenopausal women evidenced greater SVR and lower CO suggest that menopause is associated with increased hemodynamic load that is sustained during mental stress. These findings are consistent with evidence from two recent trials that hormone therapy reduced SVR and increased CO among postmenopausal 23 and perimenopausal 24 women. Increased vascular resistance may be involved in the higher levels of ambulatory BP observed among postmenopausal women. 25, 26 Furthermore, increased hemodynamic load associated with menopause may have pathophysiological consequences, as adverse left ventricular remodeling has been reported as an early sequel of menopause. 27 There are several possible mechanisms for menopauserelated increases in SVR. Increased SNS activity after men-opause may explain increased SVR among postmenopausal women, which is suggested by evidence that hormone therapy has been shown to reduce SNS activity 23, 28, 29 and NEmediated vasoconstriction. 29 Postmenopausal women in the present study also exhibited higher plasma NE levels than did premenopausal women. In addition, increased SVR among postmenopausal women may reflect altered AR functioning. Reduced A-AR and/or increased >-AR responsiveness would favor an increased SVR. In the present study, we found that A-AR responsiveness estimated by isoproterenol infusion (CD 25 ) was significantly lower in postmenopausal women than in premenopausal women. However, this difference was not robust because it was no longer evident after controlling for age. Nonetheless, blunted A-AR responsiveness may be one mechanism contributing to increased SVR observed in postmenopausal women. Our observations also showed that stress did not moderate menopausal differences in cardiovascular hemodynamics, which is consistent with an interpretation that menopause status was unrelated to stress response, but instead represented an altered physiological foundation supporting hemodynamic differences that persisted across a range of stimulus conditions. Postmenopausal alterations in several other regulatory systems may also contribute to increased SVR. Impaired vascular endothelial function, which is well documented to occur in postmenopausal women, may increase vascular resistance. 30<34 Postmenopausal impairment of endothelial function may be due to the decline in estrogen-potentiated vasodilation. 35<37 Estrogen seems to increase blood flow by enhancing nitric oxide bioavailability, thus improving endothelium-dependent vasodilation. 38<40 A recent study reported that menopause exacerbates the age-related increase in arterial stiffness during the early postmenopausal phase and that this augmentation is probably related, at least in part, to estrogen deficiency. 41 Another study showed that surgically induced menopause causes an increase in peripheral vascular resistance and BP, suggesting a role of ovarian hormones in homeostatic pressure modulation. 41, 42 Estrogen also modulates calcium influx into smooth muscle cells, reducing contractile activity. 40 There are several limitations to the present study. First, our sample size is relatively small. Comparatively, however, it did exceed the size of most other study populations characterizing cardiovascular and endothelial responses to mental stress. 43, 44 We also made many statistical comparisons, which, in a study of our sample size, may have given rise to findings by chance. Another limitation is that the premenopausal women were not assessed during a controlled menstrual cycle phase. There is some evidence suggesting that natural hormonal fluctuations may alter sympathetic outflow and the regulation of vascular resistance. 45, 46 
CONCLUSIONS
In summary, after menopause, women may be characterized by increased hemodynamic load that is sustained during mental stress. Altered SNS activity may be one mechanism leading to increased vascular resistance in postmenopausal women. Increased hemodynamic load after menopause may contribute to pathological structural and functional changes in the heart and blood vessels that are characteristic of postmenopausal women.
